
Hedge funds are not a guaranteed success in institutional portfolios. This makes the experience of the North Rhine Medical Pension Fund (NÄV) all the more intriguing; since 2007, it has consistently invested in funds of hedge funds and has successfully developed this component across a wide range of market phases.
In a recent interview with Dr. Guido Birkner (dpn), Andreas Reichel (NÄV) and our colleagues Michael Billmann and Dr. Marc-André Göricke discuss the role that market-independent returns, diversification, and alpha generation play today, and why a deep understanding of the strategies as well as a critical cost-benefit analysis are crucial.
We would like to thank Andreas Reichel and the entire NÄV team for their long-standing trust and their consistently professional and pleasant collaboration.
You can find the full interview here (German language): dpn Interview
Please feel free to call or write us and we will get back to you in a timely manner.
